Is Melatonin a Medication or a Supplement? The Classification That Changes Everything

Written by the Nuvirox Research Team

Short answer: melatonin is pharmacologically a hormone, legally a dietary supplement in the United States, and a prescription medication in most of the developed world. The US classification is the global outlier—a consequence of a 1994 law rather than a scientific determination that melatonin is nutritionally equivalent to a vitamin. Understanding what melatonin actually is—and what that means for safety, dosing precision, and drug interactions—matters regardless of which category your country places it in.

What is melatonin, biologically?

Melatonin (N-acetyl-5-methoxytryptamine) is an endogenous hormone produced primarily by the pineal gland, a small structure in the brain. Its synthesis is triggered by darkness: light reaching the retina suppresses pineal melatonin production, while darkness activates the synthesis pathway via the suprachiasmatic nucleus (SCN) of the hypothalamus, the brain's master circadian clock. Endogenous melatonin rises in the evening, peaks between 2–4am in most adults, and falls before waking.

Melatonin acts on MT1 and MT2 receptors in the SCN and other brain regions to signal the biological "time of night," facilitating the transition to sleep and coordinating circadian-dependent physiology including body temperature, cortisol rhythm, and immune function. It is not a sedative in the pharmacological sense—it does not work through GABA or histamine pathways like sleep medications. It adjusts timing, not depth or duration of sleep directly.

As a hormone, melatonin's classification as a dietary "supplement" in the United States is genuinely anomalous. Estrogen, testosterone, thyroid hormone, and cortisol—all hormones—are tightly regulated as prescription medications in the US. Melatonin ended up differently because of legislative timing: the Dietary Supplement Health and Education Act (DSHEA) of 1994 was passed at a moment when melatonin was gaining enormous popular attention as a "wonder supplement," and the legislation specifically excluded from drug classification substances that were being sold as supplements before the law's enactment—which melatonin was.

What are the real-world consequences of the classification difference?

The classification is not merely semantic. It has four concrete consequences worth understanding:

1. Quality control: Pharmaceutical-grade melatonin (as dispensed in the UK under prescription, or as Circadin in the EU) must meet pharmacopoeial purity and potency standards, with batch testing. Dietary supplement melatonin sold OTC in the US has no such requirement. As detailed in our companion article on melatonin over the counter, an analysis of 31 OTC supplements found melatonin content ranging from 83% less to 478% more than labeled—and 26% of products contained measurable serotonin contamination. This is a quality control gap, not a safety crisis, but it means the dose you intend and the dose you receive may differ substantially.

2. Prescriber oversight: In prescription markets, a doctor or pharmacist reviews your other medications and health conditions before recommending melatonin. In the US OTC market, that screening does not happen. This matters because melatonin has documented drug interactions (see below) that most OTC supplement purchasers are never informed about.

3. Approved indications: Pharmaceutical melatonin products in the EU (specifically the prolonged-release formulation Circadin) are approved for the short-term treatment of primary insomnia in adults aged 55 and over. The FDA has approved melatonin receptor agonists—ramelteon (Rozerem) and tasimelteon (Hetlioz)—as prescription drugs for specific sleep disorders, but not melatonin itself. This means in the US, melatonin's evidence base informs use but no regulatory body has formally validated its clinical use case the way the EMA has.

4. Dose standardization: Prescription pharmaceutical products come in standardized, validated doses. US OTC melatonin products range from 0.1 mg to 60 mg in commercially available products, with no regulatory ceiling. The mismatch between commonly sold doses (3–10 mg) and evidence-supported doses (0.3–1 mg for sleep onset) is partly a product of the supplement regulatory environment—there is no body requiring manufacturers to sell the evidence-supported dose rather than the largest number that looks impressive on a label.

What drug interactions does melatonin have?

This section covers the most clinically documented interactions, based on the pharmacological properties of melatonin. Anyone taking prescription medications should discuss melatonin use with a pharmacist or prescriber before beginning supplementation.

Anticoagulants (especially warfarin): Melatonin may enhance the anticoagulant effect of warfarin, potentially increasing bleeding risk. A case report in the Cochrane review noted this interaction as requiring investigation. The mechanism likely involves CYP enzyme competition. If you take warfarin or any blood thinner, this interaction requires discussion with your prescriber.

CYP1A2 inhibitors and inducers: Melatonin is primarily metabolized by the cytochrome P450 enzyme CYP1A2 in the liver. Drugs that inhibit CYP1A2 (fluvoxamine, ciprofloxacin, some oral contraceptives) can dramatically increase melatonin plasma levels—fluvoxamine alone can increase melatonin levels more than 10-fold. Drugs that induce CYP1A2 (rifampicin, carbamazepine, some anticonvulsants) can reduce melatonin levels. Caffeine also competes for CYP1A2 metabolism. These interactions affect how much melatonin actually reaches your circulation from a given dose.

CNS depressants: Melatonin may add to the sedative effects of benzodiazepines, z-drugs (zolpidem, zopiclone), and other CNS depressants. This is an additive effect rather than a pharmacokinetic interaction, but it is relevant for people who take prescription sleep medications or anti-anxiety drugs.

Immunosuppressants: Melatonin has immunomodulatory properties. Some evidence suggests it can interfere with the efficacy of cyclosporine and other immunosuppressants, though human data are limited. People who have received organ transplants or take immunosuppressive therapy should not begin melatonin without medical guidance.

Epilepsy medications: The Cochrane review flagged the need for investigation of melatonin's effects in people with epilepsy. Melatonin may affect seizure threshold and potentially interact with anticonvulsants; this population should use melatonin only under medical supervision.

Is there an FDA-approved version of melatonin as a drug?

Not as melatonin itself. The FDA has approved two melatonin receptor agonists—ramelteon (Rozerem) and tasimelteon (Hetlioz)—as prescription drugs for specific indications (chronic insomnia and non-24-hour sleep-wake disorder, respectively). These are synthetic melatonin receptor agonists, not melatonin, and they were developed through the full pharmaceutical drug approval pathway. In the EU, Circadin (prolonged-release melatonin 2 mg) has pharmaceutical drug approval for primary insomnia in adults 55 and over, granted by the European Medicines Agency in 2007. This means pharmaceutical-grade melatonin at a specific dose does have regulatory approval—just not in the United States, where the DSHEA supplement classification has made that pathway economically unattractive for manufacturers.

What melatonin as a "medication" won't do

Whether you obtain melatonin as an OTC supplement or a prescription product, the underlying pharmacology is the same. It is a circadian timing hormone, not a sedative, and it does not have the same mechanism or magnitude of effect as FDA-approved insomnia medications like zolpidem, eszopiclone, or doxepin. For primary chronic insomnia in adults with normal circadian alignment, melatonin's evidence-based benefit is modest—reducing sleep onset latency by roughly 7 minutes and total sleep time by about 8 minutes compared to placebo in meta-analyses. Prescription sleep medications produce substantially larger acute effects. Melatonin's advantages over pharmaceuticals are a favorable safety and tolerance profile, no dependence potential, and specific appropriateness for circadian-based sleep problems. See a doctor if your sleep problems are significantly impairing your daytime function, if you take prescription medications that might interact, or if you are considering stopping a prescription sleep medication in favor of melatonin.

Frequently asked questions

Is melatonin the same as a sleeping pill?
No. Prescription sleeping pills—benzodiazepines, z-drugs, doxepin—work through GABA or histamine pathways to induce sedation regardless of circadian phase. Melatonin works through MT1/MT2 receptors to adjust circadian timing. This makes melatonin suitable for circadian-based problems (jet lag, shift work, delayed sleep phase, mild sleep onset delay) but less effective for general chronic insomnia driven by anxiety, hyperarousal, or other non-circadian mechanisms.

Can I take melatonin if I take prescription sleep medication?
Discuss with your prescriber. The CNS depressant interaction is real—adding melatonin to a prescription sleep medication may enhance sedation. Whether that is acceptable depends on the doses involved and your individual response. Never stop a prescription sleep medication to take melatonin without medical guidance; abrupt discontinuation of some sleep medications can cause rebound insomnia or withdrawal.

Does melatonin show up on drug tests?
No. Standard workplace drug tests do not screen for melatonin or its metabolites. Melatonin is not a controlled substance in any jurisdiction.

Is synthetic melatonin (supplement) identical to the melatonin my body makes?
Yes, molecularly. Supplemental melatonin sold in the US is synthetic and chemically identical to endogenous melatonin (N-acetyl-5-methoxytryptamine). It binds the same receptors with the same affinity. The difference from endogenous melatonin lies not in the molecule but in the timing, dose, and delivery—the supplement provides a bolus dose at an externally determined time, rather than the gradual, darkness-triggered release the pineal gland produces.

The bottom line

Melatonin is a hormone that the US happens to regulate as a supplement—not because regulators concluded it has no meaningful pharmacological effects, but because a 1994 law created a framework that allowed it. The practical consequences of that classification include dosing variability in OTC products, absence of pre-market quality testing, and no routine prescriber review of interactions. Understanding this helps you use melatonin more intelligently: choose third-party tested products to reduce dosing uncertainty, be aware of interactions if you take other medications, and use doses consistent with what clinical evidence actually supports rather than what the supplement aisle suggests. For more on what doses the evidence supports, see our article on melatonin dosage and specifically on melatonin 300 mcg, where the case for lower physiological doses is detailed.

References

1. National Institutes of Health – StatPearls. Melatonin. Updated 2024. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK534823/
2. Dietary Supplement Health and Education Act of 1994 (DSHEA). Public Law 103-417. US Congress.
3. Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275-281. PMCID: PMC5263069.
4. Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. PMCID: PMC8958662.
5. European Medicines Agency. Circadin (melatonin) — product information. EMA, 2007.
6. Andersen LP et al. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol Toxicol. 2016;17:8. DOI: 10.1186/s40360-016-0052-2.
7. Ferracioli-Oda E et al. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE. 2013;8(5):e63773. PMCID: PMC3656905.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.